SCHEMBL7666782

SCHEMBL7666782

CCCc1cnc(-c2ccc(Br)cc2Oc2ccccc2)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ SLC6A4 P31645 3/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ GCK P35557 1/20 0.35
▸ BCL2L2 Q92843 1/20 0.34
▸ FYN P06241 1/20 0.34
▸ FEN1 P39748 2/20 0.33
▸ LTA4H P09960 2/20 0.33
▸ ALOX5AP P20292 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ SREBF2 Q12772 1/20 0.33
▸ ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7664751 0.85 HTR2A (0.40) SLC6A4BCL2L2FEN1ALOX5APPOLB
SCHEMBL7664372 0.85 PLAU (0.41) NPC1GAARAB9ASMN1; SMN2L3MBTL1
SCHEMBL7670839 0.85 CYP11B1 (0.41) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL7672934 0.82 TTR (0.34) GAASLC6A4BCL2L2FYNFEN1
SCHEMBL7664066 0.76 BCL2L2 (0.37) SLC6A4BCL2L2FYNFEN1LTA4H
SCHEMBL7666933 0.76 CYP11B1 (0.42) SMN1; SMN2BCL2L2FEN1LTA4HSREBF2
SCHEMBL7666947 0.74 FEN1 (0.38) BCL2L2FYNFEN1ALOX5APPOLB
SCHEMBL7667019 0.70 TRPA1 (0.41) FEN1ALOX5APL3MBTL1SREBF2
SCHEMBL7664382 0.69 SLC6A2 (0.43) NPC1RAB9ASLC6A4L3MBTL1SREBF2
SCHEMBL7664578 0.68 GRM5 (0.38) SMN1; SMN2FEN1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 — — US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 — — US disclosed
Send feedback